BOLALAR VA O'SMIRLARDA SIL MENINGITI: XAVF OMILI, DIAGNOZ VA KASALLIK NATIJALARI
Abstract
Background: Drug-resistant pulmonary tuberculosis (DR-TB) remains one of the most significant challenges in global tuberculosis control. Treatment regimens for multidrug-resistant and extensively drug-resistant tuberculosis involve prolonged use of multiple anti-tuberculosis drugs, often resulting in adverse drug reactions (ADRs) that may affect treatment adherence and outcomes.
Keywords:
References
Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, Becerra MC. Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2014;14(10):947–957.
Marais S, Thwaites GE, Schoeman JF, Török ME, Misra UK, Prasad K, et al. Tuberculous meningitis: a uniform case definition for use in clinical research. The Lancet Infectious Diseases. 2010;10(11):803–812.
Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. The Lancet Neurology. 2013;12(10):999–1010.
Donald PR. Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. Tuberculosis. 2010;90(5):279–292.
Seddon JA, Tugume L, Solomons R, Prasad K, Bahr NC. The current global situation for tuberculous meningitis. Current Opinion in Neurology. 2022;35(3):295–303.
Wilkinson RJ, Rohlwink U, Misra UK, van Crevel R, Mai NTH, Dooley KE, et al. Tuberculous meningitis. Nature Reviews Disease Primers. 2017;3:17071.
Perez-Velez CM, Marais BJ. Tuberculosis in children. New England Journal of Medicine. 2012;367(4):348–361.
Solomons RS, Visser DH, Marais BJ, Schoeman JF, van Furth AM. Diagnostic challenges in childhood tuberculous meningitis. Pediatric Infectious Disease Journal. 2019;38(8):e184–e191.
Schoeman JF, Janse van Rensburg A, Laubscher JA, Springer P. Neurodevelopmental outcome in childhood tuberculous meningitis. Developmental Medicine & Child Neurology. 2021;63(7):824–831.
Readership
Downloads
Published
Issue
Section
How to Cite
